Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,604,477,945
-$282,311,855 QoQ
Shares Held
12,699,683
-6.2% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#19
of 2,275 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. GILD ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,604,477,945 | 12,699,683 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,886,789,800 | 13,537,991 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,952,462,488 | 15,907,304 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,843,657,274 | 25,618,534 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,161,007,640 | 37,530,510 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,065,572,247 | 27,358,967 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,293,822,472 | 35,659,007 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,900,920,673 | 34,600,676 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,573,576,041 | 22,935,083 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,506,587,831 | 20,567,752 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,509,227,150 | 18,630,134 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,219,992,021 | 16,279,584 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,282,560,556 | 16,641,502 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $340,359,199 | 4,102,196 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $257,484,322 | 2,999,235 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,229,948 | 295,509 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $20,283,504 | 328,159 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $43,368,474 | 729,495 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $51,270,208 | 706,104 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $20,311,469 | 290,787 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,936,054 | 304,038 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $33,378,613 | 516,457 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $43,030,425 | 738,593 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $50,830,601 | 804,409 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $72,957,043 | 948,233 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $161,026,981 | 2,153,919 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||